A Passion for Science and a Commitment to Dermatology

Dermavant Sciences is a clinical-stage biopharmaceutical company whose goal is to develop and commercialize innovative therapies for inflammatory skin diseases and medical dermatologic conditions. Our current pipeline consists of five product candidates intended to improve patients’ lives by targeting five different conditions with significant unmet medical needs. The patient is at the heart of everything we do.

Learn More

Latest News

December 6, 2018

Dermavant Sciences to Present New Data on Cerdulat ...

Read More

November 15, 2018

Dermavant Appoints Todd Zavodnick as Chief Executi ...

Read More

October 11, 2018

Dermavant Sciences to Present Tapinarof Phase 2B D ...

Read More